LINACS

Drug Index Methods Publications News About

Home › Targeted Therapy › Anti-VEGF

Drug Class

Anti-VEGF

Aflibercept

Bevacizumab Ramucirumab

LINACS · Living systematic review on the safety of SBRT combined with systemic therapies
EORTC-ESTRO · OligoCare · PROSPERO CRD42024559453